Ligand saves $15M CVR as it licenses DARA to Retrophin
21 February 2012
Sukaina Virji
Please Login to read the full article.
21 February 2012
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Australia's Biota merges with Nabi for cash and exposure to larger US investment market
- Allos buy could be silver lining for Spectrum after cancer drug setback
- Ajinomoto becomes first partner for Albireo's lead drug elobixibat
- Alkermes' PhII ALKS-5461: new mechanism, opiate receptor modulation, for refractory depression
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
